The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Information Update

14 Jun 2010 09:16

RNS Number : 5424N
PuriCore Plc
14 June 2010
 



PuriCore plc Annual Information Update

MALVERN, PENNSYLVANIA, AND STAFFORD, UK, 14 June 2010 - PuriCore (LSE: PURI), the water-based clean technology company focused on developing and commercialising proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens, today sets out below a list of the information that has been published or made available to the public over the previous 12 months, up to and including 28 May 2010.

 

The Company announces that, in accordance with Rule 5.2 of the Prospectus Rules, the following information was published or made available to the public during the 12-month period between 28 May 2009 and 28 May 2010. In accordance with Prospectus Rule 5.2.7, it is acknowledged that whilst the information referred to above was up to date at the time of publication, such disclosures may, at any time, become out of date due to changing circumstances. For the purposes of this update, the information is referred to rather than provided in full. Full copies of each item can be found in the locations specified below.

 

1. Announcements made via the Regulatory Information Service

 

All the announcements listed below can be obtained from the London Stock Exchange website, www.londonstockexchange.com/marketnews or from the Company's website, www.puricore.com.

 

Date

Headline

28/05/2010

PuriCore plc - Publication of Circular

28/05/2010

PuriCore plc - Resumption of Trading

28/05/2010

PuriCore plc - Official List - Restoration

28/05/2010

PuriCore plc - Interim Management Statement

28/05/2010

PuriCore plc - Final Results

28/05/2010

PuriCore plc - Issue of Secured Convertible Loan Notes

24/05/2010

PuriCore plc - Holding(s) in Company

30/04/2010

PuriCore plc - Temporary Suspension

30/04/2010

PuriCore plc - Official List - Temporary Suspension - PuriCore plc

23/04/2010

PuriCore plc - PuriCore Raises $1.8 Million

24/02/2010

PuriCore plc - Blocklisting Interim Review

20/01/2010

PuriCore plc - Trading Statement

12/11/2009

PuriCore plc - Change of Adviser

03/11/2009

PuriCore plc - Interim Management Statement

02/11/2009

PuriCore plc - Darren Weiss promoted to CFO & Executive Director

15/09/2009

PuriCore plc - Holding(s) in Company

02/09/2009

PuriCore plc - Holding(s) in Company

27/08/2009

PuriCore plc - Total Voting Rights

25/08/2009

PuriCore plc - Holding(s) in Company

25/08/2009

PuriCore plc - Interim Results

25/08/2009

PuriCore plc - PuriCore New $2.1 Million Facility

05/08/2009

PuriCore plc - Trading Statement

05/08/2009

PuriCore plc - Acquisition and Placing

04/08/2009

PuriCore plc - Blocklisting Interim Review

24/07/2009

PuriCore plc - Second Price Monitoring Extn

24/07/2009

PuriCore plc - Price Monitoring Extension

10/07/2009

PuriCore plc - Second Price Monitoring Extn

10/07/2009

PuriCore plc - Price Monitoring Extension

07/07/2009

PuriCore plc - Second Price Monitoring Extn

07/07/2009

PuriCore plc - Price Monitoring Extension

17/06/2009

PuriCore plc - Presenting at Piper Jaffray European Conference

05/06/2009

PuriCore plc - Result of AGM

28/05/2009

PuriCore plc - US retailer extends use of Sterilox Systems

 

 

2. Documents filed at Companies House

 

Copies of these documents can be obtained from Companies House at Crown Way, Maindy, Cardiff CF14 3UZ or from Companies House website www.companieshouse.co.uk.

 

Date

Document

Description

11/06/2010

PR03

Proof; Consent form for filing

11/06/2010

AR01

Annual Report and Accounts 2009

08/04/2010

MG01

Particulars of a Mortgage or Charge/Charge No:1

12/03/2010

AD01

Registered Office Changed on 12/3/2010 from 58 Davies Street, London, W1K 5JF

03/11/2009

AP01

Director Appointed Chief Financial Officer Darren Douglas Weiss

24/10/2009

AD03

Register(s) moved to Sail Address 114-Reg Mem 809-Reg INT in shares Disc to Pub Co

24/10/2009

AD02

Sail Address created

04/07/2009

RES13

Adopt Financial Statements 05/06/2009

25/06/2009

363a

Return made up to 21/04/09; Full List of Members

22/06/2009

AA

Group of Companies Accounts made up to 31/12/08

28/05/2009

288c

Director's Change of Particulars/ Tim Anderson 24/04/2009

12/05/2009

288c

Director's Change of Particulars/Joseph Birkett 04/05/2009

 

 

3. Documents published and sent to shareholders

 

Date

Document Description

28/05/2010

Annual Report and Accounts 2009, Notice of Annual General Meeting, and Form of Proxy

28/05/2010

Circular, Notice of General Meeting, and Form of Proxy

 

 

4. Documents filed with the UKLA Documents Viewing Facility

 

Date

Document Description

28/05/2010

Notice of General Meeting Circular

28/05/2010

2009 Annual Report and Accounts

28/05/2010

Prelim Q1 2010 Results

28/05/2010

Prelim-Full Year 2009 Results

20/01/2010

Earnings

27/08/2010

Interim Results 2009

25/08/2010

Interim Results 2009

09/06/2009

Annual General Meeting Circular

 

Copies of these documents can be obtained from:

 

Registered Office

PuriCore plc

26-28 Mount Row

London

W1K 3SQ

UK 

 

Andrea Holtzman Drucker

Company Secretary

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUMMGMVRDKGGZG
Date   Source Headline
9th Oct 20185:02 pmRNSForm 8.3 - Realm Therapeutics PLC
9th Oct 201810:13 amRNSForm 8.3 - Realm Therapeutics plc
5th Oct 20186:08 pmBUSForm 8.3 - Realm Therapeutics PLC
5th Oct 20182:00 pmRNSFORM 8.3 - Realm Therapeutics Plc
4th Oct 20188:57 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics plc
2nd Oct 201810:43 amRNSForm 8.5 (EPT/RI) - Realm Therapeutics PLC
1st Oct 20187:00 amRNSProvides Update on Timing of Formal Sale Process
24th Sep 20189:59 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
21st Sep 201811:33 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20185:06 pmRNSForm 8.3 - Realm Therapeutics plc
20th Sep 20183:16 pmRNSHolding(s) in Company
20th Sep 201811:53 amRNSForm 8.3 - REALM THERAPEUTICS PLC
20th Sep 201811:18 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
19th Sep 20184:31 pmRNSForm 8 (OPD) - Realm Therapeutics plc
19th Sep 201811:11 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
18th Sep 201811:19 amRNSForm 8.5 (EPT/RI) Realm Therapeutics
17th Sep 20187:00 amRNSCorporate Update and Hiring of Advisor
20th Aug 201811:00 amRNSPrice Monitoring Extension
20th Aug 20187:00 amRNSBlock listing Interim Review
15th Aug 20184:35 pmRNSPrice Monitoring Extension
14th Aug 20187:10 amRNSHalf-year Report
8th Aug 20187:00 amRNSPresents at Wedbush PacGrow Healthcare Conference
7th Aug 20187:00 amRNSNotice of Results
16th Jul 20185:33 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSPre-Clinical Study in Atopic Dermatitis
4th Jul 20187:00 amRNSInstructions for Exchanging Ordinary Shares
4th Jul 20187:00 amRNSSEC registration effective NASDAQ listing approved
14th Jun 201810:54 amRNSResult of AGM
31st May 20187:00 amRNSRealm to Present at June Investor Conferences
24th May 20187:00 amRNSEnrollment complete for Phase 2 study of PR022
23rd May 20187:00 amRNSFiling with US SEC to Facilitate Nasdaq Listing
21st May 20187:00 amRNSData Presentation at IID 2018
2nd May 201812:39 pmRNSAnnual Financial Report Available
2nd May 20187:00 amRNSFinal Results
2nd May 20187:00 amRNSRealm Files Registration for Nasdaq Listing of ADS
26th Apr 20182:32 pmRNSNotice of Results
12th Mar 20184:40 pmRNSSecond Price Monitoring Extn
12th Mar 20184:35 pmRNSPrice Monitoring Extension
12th Mar 20187:00 amRNSClinical Update including PR013 Phase II results
8th Mar 20187:00 amRNSPresenting at Cowen Healthcare Conference
27th Feb 20187:00 amRNSPatent portfolio strengthened with USPTO allowance
20th Feb 201812:00 pmRNSPresentation at RBC Healthcare Conference
16th Feb 20187:00 amRNSBlock listing Interim Review
15th Feb 20187:00 amRNSClinical and Business Update
2nd Jan 20187:00 amRNSPresents at 5th Annual Dermatology Summit
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
12th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR013
5th Dec 20177:00 amRNSFirst Patient Dosed in Phase 2 Study of PR022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.